Clinical Trials Logo

Clinical Trial Summary

This is a diagnostic evaluation comparing the performance of real-time PCR performed at a national reference laboratory and a LAMP assay performed at a regional hospital for the diagnosis of yaws


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04753788
Study type Observational
Source London School of Hygiene and Tropical Medicine
Contact
Status Active, not recruiting
Phase
Start date March 15, 2021
Completion date May 2024

See also
  Status Clinical Trial Phase
Completed NCT01382004 - Single-dose Azithromycin for the Treatment of Yaws Phase 3
Completed NCT03664063 - PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs ) Phase 2
Completed NCT03676140 - Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) Phase 3
Completed NCT04453124 - An Accessible Low-cost Plant Treatment for Cutaneous Ulcers Phase 2
Completed NCT01955252 - Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea Phase 3
Active, not recruiting NCT05764876 - Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws) Phase 3
Completed NCT02344628 - Comparison of Two Different Doses of Azithromycin for Treatment of Yaws Phase 3
Completed NCT03683745 - Integrated Mapping of Skin-presenting Neglected Tropical Diseases in Liberia
Completed NCT02775617 - Azithromycin - Ivermectin Mass Drug Administration for Skin Disease Phase 4
Completed NCT01841203 - Dual Point-of-care Test for the Diagnosis of Yaws N/A
Completed NCT03490123 - Evaluation of an Intensive 3-round MDA Strategy Towards Yaws Eradication Phase 4